Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Chicago
Wake Forest University Health Sciences
University of Chicago
M.D. Anderson Cancer Center
ALX Oncology Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Pittsburgh
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Rutgers, The State University of New Jersey
Stanford University
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
George Washington University
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of California, Davis
UNC Lineberger Comprehensive Cancer Center
Odense University Hospital
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
University of Maryland, Baltimore
Daiichi Sankyo
European Organisation for Research and Treatment of Cancer - EORTC
University of Maryland, Baltimore
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
SCRI Development Innovations, LLC
National Cancer Institute (NCI)